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Abstract: 
Background: The extended spectrum beta-lactamase (ESBL)-producing Escherichia coli strains which have been 
implicated in septicaemia among hospitalized children is a serious concern due to their high resistance rates to 
commonly used antimicrobial agents. The objective of this study was to determine the prevalence and antibiotic 
susceptibility of urinary ESBL-producing E. coli in paediatric patients who had clinical evidence of urinary tract 
infections (UTI).                                                           
Methodology: Clean catch specimens of urine collected from 100 eligible paediatric patients with clinical evidence 
of UTI in St. Patricks’ Hospital, Mile Four, Abakaliki, Ebonyi State, were cultured for isolation of E. coli using 
standard bacteriological techniques. Isolates were confirmed for ESBL production by double disk synergy test 
(DDST), and antibiotic susceptibility of the ESBL-producing ones was determined by the modified Kirby Bauer disk 
diffusion method.                                                                        
Results: Twenty one (21%) E. coli were isolated out of which 11 (52 %) were ESBL producers, all of which were 
totally resistant (100%) to cefotaxime, ticarcillin and sulfamethoxazole-trimethoprim, 85% to aztreonam and 83% 
to ceftazidime. The multiple antibiotic resistance index (MARI) values ranged from 0.4 to 0.9, which implies high 
usage of antimicrobials                                         
Conclusion: The high prevalence of multi-drug resistant ESBL-producing E. coli obtained in this study shows that 
there has been overuse (abuse or misuse) of antibiotics in the study area. There is need for antimicrobial 
stewardship programme that will ensure prudent use of antimicrobial agents to forestall the emergence and spread 
of multi-drug resistant bacteria. 
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Contexte: Les souches d'Escherichia coli productrices de bêta-lactamase à spectre étendu (BLSE) qui ont été 
impliquées dans la septicémie chez les enfants hospitalisés constituent un grave problème en raison de leur taux 
de résistance élevé aux agents antimicrobiens couramment utilisés. L'objectif de cette étude était de déterminer la 
prévalence et la sensibilité aux antibiotiques d'E. coli producteurs de BLSE dans l'urine chez les patients 
pédiatriques présentant des signes cliniques d'infections des voies urinaires (UTI).                  
Méthodologie: Des échantillons d’urine prélevés chez 100 patients pédiatriques éligibles présentant des signes 
cliniques d’UTI à l’hôpital St. Patricks, à Mile Four, à Abakaliki, dans l’État d’Ebonyi, ont été cultivés pour 
l’isolement de E. coli à l’aide de techniques bactériologiques classiques. Les isolats ont été confirmés pour la 
production de BLSE par un test de synergie à double disque (DDST) et la sensibilité aux antibiotiques des 
producteurs de BLSE a été déterminée par la méthode de diffusion sur disque de Kirby Bauer modifiée.             
Résultats: Vingt et un (21%) E. coli ont été isolés, dont 11 (52%) étaient des producteurs de BLSE, qui étaient 
tous totalement résistants (100%) au céfotaxime, à la ticarcilline et au sulfaméthoxazole-triméthoprime, 85% à 
l'aztréonam et au 83 % en ceftazidime. Les valeurs de l'indice de résistance multiple aux antibiotiques (MARI) 
allaient de 0,4 à 0,9, ce qui implique une utilisation élevée d'antimicrobiens                    
Conclusion: La prévalence élevée d'E. coli productrice de BLSE résistante à plusieurs médicaments obtenue dans 
cette étude montre qu'il y a eu surutilisation (abus ou abus). ) d'antibiotiques dans la zone d'étude. Un programme 
de gestion des antimicrobiens est nécessaire pour garantir une utilisation prudente des agents antimicrobiens afin 
de prévenir l'émergence et la propagation de bactéries multirésistantes aux médicaments 
Mots-clés: pédiatrie, Escherichia coli, BLSE, urine, multirésistance 
Introduction: 
 Beta-lactam antibiotics are the most 
commonly used therapeutic agents, accounting 
for over 50% of antibiotics used for treatment 
of bacterial infections, due to their broad 
antibacterial spectrum and excellent safety 
profile (1). The use of β-lactam antibiotics had 
however been hampered by β-lactamases 
which are enzymes that inactivate the β-
lactam ring of the antibiotics thereby rendering 
them ineffective. The extended spectrum β-
lactamases (ESBLs) produced by Gram-
negative bacilli such as Escherichia coli have 
the ability to hydrolyse β-lactams including the 
third generation cephalosporins and aztreonam 
and yet are inhibited by clavulanic acid. ESBLs 
are mostly plasmid-mediated and can be 
transferred from one strain to another among 
bacterial species.    
 The prevalence of antibiotic resistance 
in bacterial species such as E. coli, Klebsiella 
and Proteus species isolated from clinical 
patients is increasing worldwide (2). In 
particular, strains of E. coli and Klebsiella 
species producing ESBL enzymes have become 
a worldwide problem with serious negative 
impact on the efficacy of β-lactam therapy. 
Thus, there is need for efficient infection 
control practices for containment of outbreaks 
of these strains.     
 The presence of ESBLs is associated 
with multi-drug resistance to various other 
classes of antibiotics such as monobactam, 
carbapenems, amino- glycosides, ciprofloxacin 
and erythromycin (1). The detection of these 
enzymes is therefore important in preventing 
treatment failures from infections caused by 
these pathogens. The objective of this study 
therefore is to determine the prevalence and 
antibiotic resistance patterns of urinary ESBL-
producing E. coli isolates from paediatric 
patients in St. Patricks’ Hospital, Mile Four, 
Abakaliki, Ebonyi State. 
Materials and methods: 
Study area                    
 St. Patrick’s hospital, Mile Four, 
Abakaliki is a missionary hospital located in 
Ebonyi State. The hospital specializes majorly 
in maternal and child care, and has an 
outpatient department (OPD), nursery ward, 
children’s ward, maternity ward, and child’s 
welfare clinic.  
Study population 
 The study population consists of 
children (15 years and below) with clinical 
evidence of UTI who were seen at the 
outpatient department (OPD), and those 




 Ethical clearance was obtained from 
the Research and Ethics committee of the 
hospital before the commencement of sample 
collection. Informed consent was also obtained 
from the parents/guardians of the children.  
 
Sample collection, culture isolation and 
biochemical identification 
 Urine sample was collected as clean-
catch early morning urine from each child into 
a sterile container free of preservatives. Each 
 




specimen was labelled accordingly with the 
date and time of collection, and identification 
number. Samples were transported 
immediately to the Laboratory unit of the 
Department of Applied Microbiology, Ebonyi 
State University, for bacteriological analysis. 
 The urine samples were cultured on 
eosin methylene blue (EMB) and MacConkey 
agar plates, and incubated aerobically at 37oC 
for 24 hours. E. coli was presumptively 
identified as green metallic sheen colonies on 
EMB agar and as non-mucoid pinkish colonies 
on MacConkey agar. The isolates were 
confirmed as E. coli using standard 
conventional biochemical identification tests 
scheme (3). 
 
Antibiotic susceptibility test of isolates 
 Antimicrobial susceptibility test of the 
isolates was done using the modified Kirby-
Bauer disk diffusion technique (4) on Mueller-
Hinton (MH) agar. Inoculum of each isolate 
prepared by suspending pure colonies of the 
bacteria from nutrient agar subculture plate in 
normal saline was standardized by comparing 
with 0.5 McFarland turbidity standards. This 
was inoculated on the surface of the MH agar 
plates with sterile swab using the following 
antibiotic disks (Oxoid, UK); cefotaxime (CTX, 
30μg), ceftazidime (CAZ, 30μg), tobramycin 
(TOB, 15μg), aztreonam (AZ, 30 μg), 
gentamicin (GEN, 10μg), sulfamethoxazole- 
trimethoprim (SXT, 75μg), ciprofloxacin (CIP, 
5μg), ertapenem (ERT, 10μg), ticarcillin (TIC, 
75μg), amikacin (AMK, 30μg), and 
amoxicillin/clavulanic acid (AMC, 25μg/10 μg).  
 The plates were incubated aerobically 
at 37°C for 18-24 hours. The zones of 
inhibition were measured with a meter rule and 
the results interpreted according to the Clinical 
and Laboratory Standards Institute guidelines 
(5). 
 
Phenotypic confirmatory test for ESBL 
production 
 Escherichia coli isolates exhibiting 
reduced susceptibility to any of the 3rd 
generation cephalosporins (suspected ESBL 
producers) were phenotypically confirmed for 
ESBL production using the double disc synergy 
test (DDST) (6). This was performed as a 
standard disc diffusion assay on Mueller-Hinton 
agar (Oxoid, UK) plates in line with CLSI 
guideline (5). Sterile swabs were dipped into 
standard bacterial suspension standardized to 
0.5 McFarland turbidity standards and 
inoculated on the MH agar plates. 
Amoxicillin/clavulanic acid (20/10 μg) disk was 
placed at the centre of the plate and 
cefotaxime (30μg) and ceftazidime (30μg) 
were placed at a distance of 15 mm (centre to 
centre) from the central disk.    
 The plates were incubated aerobically 
at 37oC for 24 hours. ESBL production was 
confirmed when the zones of inhibition of the 
cephalosporins (cefotaxime and ceftazidime) 
increased in the presence of amoxicillin-
clavulanic acid disk. A ≥ 5mm increase in the 
inhibition zone diameter for either of the 
cephalosporins tested in combination with 
amoxicillin-clavulanic acid over the zone when 
tested alone, confirmed ESBL production (6). 
E. coli ATCC 25922 was used as quality control 
strain. 
 
Determination of multiple antibiotic resistance 
index (MARI) 
 Multiple antibiotic resistance index 
(MDRI) was calculated as MDRI = a/b where ‘a’ 
is the number of antibiotics to which the isolate 
was resistant to, while ‘b’ is the total number 





 Twenty one E. coli were isolated from 
urine samples of 100 children studied; 9 
isolates were from those in age group < 5 
years, 4 (44.4%) of which were ESBL 
producing; 4 isolates were from those in age 
group 5-10 years, 2 (50%) of which were ESBL 
producer; and 8 isolates were from age group 
11-15 years, 5 (62.5%) of which were ESBL 
producers (X2 = 0.1740, p = 0.9167) (Table 1) 
 ESBL-producing E. coli isolates were 
totally resistant to cefotaxime, aztreonam, 
ticarcillin, sulfamethoxazole-trimethoprim and 
ciprofloxacin among children aged <5 years. 
Isolates also exhibited total resistance to 
cefotaxime, ceftazidime, ticarcillin and 
sulfamethoxazole-trimethoprim among children 
aged 5-10 years, and similarly, there was total 
resistance of isolates to cefotaxime, 
aztreonam, ticarcillin and sulfamethoxazole-
trimethoprim from children aged 11- 15 years 









Table 1: Frequency of Escherichia coli and ESBL producing isolates from urine samples of paediatrics patients in St 




No of urine samples No of Escherichia coli isolates (%)  No of ESBL-producing E. coli 
isolates (%) 
< 5 34   9 (26.5)  4 (44.4) 
5 – 10 39                     4 (10.3)  2 (50.0) 
11 – 15 27   8 (29.6)  5 (62.5) 
Total 100   21 (21.0)  11 (52.4) 
X2 = 0.1740, p = 0.9167 (no significance difference) 
 
 
Table 2: Antibiotic susceptibility of ESBL-producing Escherichia coli urinary isolates from children at St. Patricks 







(n = 4) 
5 – 10 
(n = 2) 
11 – 15 
(n = 5) 
Susceptible Resistance Susceptible Resistance Susceptible Resistance 
Cefotaxime (30) 0 4 0 2 0 5 
Ceftazidime (30) 1 3 0 2 1 4 
Aztreonam (30) 0 4 1 1 0 5 
Amikacin (30) 2 2 2 0 4 1 
Ticarcillin (75) 0 4 0 2 0 5 
Ertapenem (10) 1 3 1 1 2 3 
Gentamicin (10) 1 3 1 1 4 1 
Sulfamethoxazole-
trimethoprim (75) 
0 4 0 2 0 5 
Ciprofloxacin (5) 0 4 1 1 1 4 
Tobramycin (15) 1 3 1 1 2 3 
n = no of Escherichia coli isolates 
 
 
Table 3: Multiple antibiotic resistance index (MARI) of the ESBL-producing Escherichia coli isolates from paediatric 
patients in St Patrick Hospital, Abakaliki, Ebonyi State, Nigeria 
 
ESBL producing Escherichia coli isolate MARI 











Average MARI = 0.9 






Average MARI = 0.7 













Average MARI = 0.7 
 
 The average multiple antibiotic 
resistance index (MARI) values of the ESBL-
producing E. coli isolates in age groups < 5 
years, 5-10 years and 11-15 years are 
respectively 0.9, 0.7, and 0.7 (Table 3). There 
was no statistically significant difference in the 
average MARI values between the age groups 




 In our study, the prevalence of E. coli 
in 100 children with urinary tract infection at 
St. Patricks Hospital, Abakaliki, Ebonyi State, 
Nigeria is 21%. In a related study by Sani et 
al., (8), the prevalence of 45% for E. coli 
 




isolates was reported in 222 urinary samples, 
and in another similar one by Sabrina et al,. 
(9), a prevalence of 37.5% for E. coli was 
reported in 280 urinary samples of children 
with urinary tract infection. Although these 
studies are similar to the present one 
conducted by us, the prevalence of E. coli in 
urinary tract infection in our study is lower 
than the prevalence in these other studies, 
probably because of the smaller sample size in 
our study.     
 In our study, 52% (11 of 21) of the E. 
coli isolates were phenotypically confirmed 
ESBL-producer, which compared with a related 
study by Amita and Rajesh who reported 58% 
E. coli to be ESBL producer in their study (10). 
In the study by Babak et al., (11), a high 
prevalence of ESBL producer in E. coli of 
68.2% in children aged 9-12 years was 
reported, which agrees with 62.5% reported 
among comparative age group (11-15 years) 
in our study. This may suggests a higher 
prevalence of ESBL producers among urinary 
E. coli isolates in older children.   
 The ESBL-producing E. coli isolates in 
our study exhibited total resistance to 
cefotaxime, ticarcillin and sulfamethoxa- 
zole/trimethoprim among the children across 
age strata, and to aztreonam, ceftazidime and 
ciprofloxacin in specific age groups. This is 
similar to the study of Rajesh et al., (12) who 
reported high resistance rates of EBSL-
producing E. coli isolates to ticarcillin, 
ampicillin, monobactam (aztreonam) and 
cephalosporins. The average multiple antibiotic 
resistance index (MARI) value of 0.8 reported 
for the ESBL-producing E. coli isolates in this 
study is an indication that antibiotics are 




 The high prevalence of multi-drug 
resistant ESBL-producing E. coli obtained from 
children with urinary tract infection in St. 
Patrick Hospital, Abakaliki, Ebonyi State, shows 
that there has been overuse (abuse or misuse) 
of antibiotics in the area. There is need for 
antimicrobial stewardship programme that will 
ensure prudent use of antimicrobial agents to 
forestall the emergence and spread of multi-
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